Article(id=1325225227176784141, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225034792444105, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.05.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1760025600000, receivedDateStr=2025-10-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887915653, onlineDateStr=2026-11-05, pubDate=1778342400000, pubDateStr=2026-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887915653, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887915653, creator=13701087609, updateTime=1793887915653, updator=13701087609, issue=Issue{id=1325225034792444105, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='5', pageStart='499', pageEnd='624', issueExtLink='null', onlineDate='null', pubDate='1778342400000', pubDateStr='2026-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887869784, creator='13701087609', updateTime=1793935334440, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325424116299342176, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225034792444105, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325424116299342177, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225034792444105, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=612, endPage=618, ext={EN=ArticleExt(id=1325225227671712014, articleId=1325225227176784141, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Thoughts on the Application of Real-world Data in Regulatory Decision-making for Pediatric Drug Development, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Xing LING1, Jie HE1, Wen GUO1, 2, *, authorsList=Xing LING, Jie HE, Wen GUO, authorCompany=null, correspAuthors=Wen GUO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325225228183417103, articleId=1325225227176784141, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=真实世界数据应用于儿童用药研发监管决策的思考, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

儿童用药因研发周期长、市场规模小及临床试验难度大,形成了高成本与低研发意愿的现状。真实世界研究作为一种新研究方法,有望成为解决儿童用药研发困境的突破口。真实世界数据(RWD)整合了电子健康档案、疾病登记等多源信息,可替代部分传统临床试验,用以支持儿童新药有效性评价、剂量优化、适应证扩展及长期安全性评价,助力完善药品说明书中的儿童用药信息。文章梳理、归纳了国内外RWD在儿童用药研发与监管决策中的应用进展,以期探讨并推动我国RWD向真实世界证据转化,加快儿童用药研发。

, authors=凌星1, 何洁1, 郭文1, 2, *, authorsList=凌星, 何洁, 郭文, authorCompany=null, correspAuthors=郭文, authorNote=

凌星,博士研究生,专业方向:医药政策与法规。

, correspAuthorsNote=
郭文,研究员,博士生导师,从事社会与管理药学的研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=EyvdieEBW6630PJXFgbnew==, magXml=V1vWTBBjgJSVnJwi4yAkqg==, pdfUrl=null, pdf=MzqxN5XIpfSrE81KgWn6ag==, pdfFileSize=1014031, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=IQQHkNRPo1I5kRknjp8P+w==, mapNumber=null, fund=null)}, authors=[Author(id=1325225895216161691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225895295853469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895216161691, language=EN, stringName=Xing LING, firstName=Xing, middleName=null, lastName=LING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225895358768030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895216161691, language=CN, stringName=凌星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海 201203, bio={"content":"

凌星,博士研究生,专业方向:医药政策与法规。

"}, bioImg=null, bioContent=

凌星,博士研究生,专业方向:医药政策与法规。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)])]), Author(id=1325225895425876896, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225895509762978, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895425876896, language=EN, stringName=Jie HE, firstName=Jie, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225895593649059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895425876896, language=CN, stringName=何洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)])]), Author(id=1325225895685923749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225895774004136, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895685923749, language=EN, stringName=Wen GUO, firstName=Wen, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.China National Pharmaceutical Industry Information Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225897460114346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895685923749, language=CN, stringName=郭文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325225895123886999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=2., ext=[AuthorCompanyExt(id=1325225895136469912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1325225895149052825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])])], keywords=[Keyword(id=1325225897640469419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, language=CN, orderNo=1, keyword=儿童用药), Keyword(id=1325225897715966892, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, language=CN, orderNo=2, keyword=真实世界数据), Keyword(id=1325225897783075757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, language=CN, orderNo=3, keyword=真实世界研究), Keyword(id=1325225897866961838, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, language=CN, orderNo=4, keyword=监管), Keyword(id=1325225897959236527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, language=CN, orderNo=5, keyword=社会与管理药学)], refs=[Reference(id=1325225898156368816, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=国家卫生健康委员会.中国卫生健康统计年鉴2023[M].北京: 中国协和医科大学出版社, 2024., articleTitle=null, refAbstract=null), Reference(id=1325225898240254897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局.各年龄段人口数[EB/OL].[2025-06-14].https://data.stats.gov.cn/ifnormal.htm?u=/files/html/vchart/vchart_002/vchart_002.html&h=730., articleTitle=null, refAbstract=null), Reference(id=1325225898328335282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=王 璐, 黄 哲.真实世界证据改善儿童药物临床试验障碍的对策研究[J].中国新药杂志, 2022, 31(19): 1872-1875., articleTitle=null, refAbstract=null), Reference(id=1325225898399638451, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population [EB/OL].[2026-01-26].https://database.ich.org/sites/default/files/E11_R1_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225898470941620, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于公开征求《真实世界证据支持药物研发的基本考虑》意见的通知[EB/OL].(2019-05-29)[2026-01-19].https://www.cde.org.cn/main/news/viewInfoCommon/7e6fb9fc3f066a966a02130f24dbff1c., articleTitle=null, refAbstract=null), Reference(id=1325225898538050485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.国家药监局关于发布真实世界证据支持药物研发与审评的指导原则(试行)的通告[EB/OL].(2020-01-03)[2026-01-19].https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20200107151901190.html., articleTitle=null, refAbstract=null), Reference(id=1325225898605159350, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《真实世界研究支持儿童药物研发与审评的技术指导原则(试行)》的通告[EB/OL].(2020-08-27)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/6906389100848948deb49a484197902b., articleTitle=null, refAbstract=null), Reference(id=1325225898701628343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则(试行)》的通告[EB/OL].(2021-04-13)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/2a1c437ed54e7b838a7e86f4ac21c539., articleTitle=null, refAbstract=null), Reference(id=1325225898772931512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《患者报告结局在药物临床研发中应用的指导原则(试行)》的通告[EB/OL].(2021-12-27)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/c2f79c22e8678241b030c71523eb300c., articleTitle=null, refAbstract=null), Reference(id=1325225898856817593, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《基于人用经验的中药复方制剂新药临床研发指导原则(试行)》《基于“三结合”注册审评证据体系下的沟通交流指导原则(试行)》的通告[EB/OL].(2022-04-29)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/8a1682a8d37494732f7f441dd11f5af6., articleTitle=null, refAbstract=null), Reference(id=1325225898940703674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《罕见疾病药物临床研究统计学指导原则(试行)》的通告[EB/OL].(2022-06-02)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/058e0d665b785e79b7f4f24dc1dc970c., articleTitle=null, refAbstract=null), Reference(id=1325225899016201147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《真实世界证据支持药物注册申请的沟通交流指导原则(试行)》的通告(2023年第6号)[EB/OL].(2023-02-6)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/8b59a85b13019b5084675edc912004f1., articleTitle=null, refAbstract=null), Reference(id=1325225899087504316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《药物真实世界研究设计与方案框架指导原则(试行)》的通告(2023年第5号).[EB/OL].(2023-02-6)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/14aac16a4fc5b5841bc2529988a611cc., articleTitle=null, refAbstract=null), Reference(id=1325225899163001789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.关于发布《单臂临床试验用于支持抗肿瘤药上市申请的适用性技术指导原则》的通告(2023年第13号)[EB/OL].(2023-03-14)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/9f0c25dee6ba6781af809b36cf682eb6., articleTitle=null, refAbstract=null), Reference(id=1325225899225916350, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《基于疾病登记的真实世界数据应用指导原则(试行)》的通告[EB/OL].(2024-11-12)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/a8d3a782d45feebfcc700e79f3d86326., articleTitle=null, refAbstract=null), Reference(id=1325225899288830911, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=南海网.患者年省约20万元!海南让这款创新药从“用得上”到“用得起”[EB/OL].(2025-03-02)[2025-06-18].https://hainan.ifeng.com/c/8hOVisgbTvF., articleTitle=null, refAbstract=null), Reference(id=1325225899368522688, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=张 豪, 耿 莹, 孙艳喆, 等.《真实世界研究支持儿童药物研发与审评的技术指导原则(试行)》起草背景及要点内容[J].中国临床药理学杂志, 2021, 37(2): 197-200., articleTitle=null, refAbstract=null), Reference(id=1325225899444020161, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=BODEMER C, KASZUBA A, KINGO K, et al.Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a phase 3 double-blind randomized, controlled trial [J].J Eur Acad Dermatol Venereol, 2021, 35(4): 938-947., articleTitle=null, refAbstract=null), Reference(id=1325225899511129026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=诺华制药.诺华可善挺®(司库奇尤单抗)在华获批儿童及青少年银屑病适应证[EB/OL].[2025-06-18].https://www.novartis.com.cn/news/novartis-cosentyx-secukinumab-approved-in-china-for-the-indication-of-psoriasis-in-children-and-adolescents., articleTitle=null, refAbstract=null), Reference(id=1325225899578237891, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=The United States Congress.21st Century Cures Act(public law 114-255)[EB/OL].[2026-01-28].https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225899653735364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=The United States Congress.Food and Drug Administration Reauthorization Act of 2017(FDARA,Public Law 115-52) [EB/OL].[2026-01-28].https://www.congress.gov/crs-product/R44961?q=%7B%22search%22%3A%22Food+and+Drug+Administration+Reauthorization+Act+of+2017+%28FDARA%2C+P.L.+115-52%29.%22% 7D&s=2&r=1., articleTitle=null, refAbstract=null), Reference(id=1325225899712455621, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Use of electronic health record data in clinical investigations: guidance for industry [EB/OL].[2026-01-28].https://www.fda.gov/media/97567/download., articleTitle=null, refAbstract=null), Reference(id=1325225899787953094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Framework for FDA’s real-world evidence program[EB/OL].[2026-01-28].https://www.fda.gov/media/120060/download?attachment., articleTitle=null, refAbstract=null), Reference(id=1325225899959919559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Submitting documents using real-world data and real-world evidence to FDA for drug and biological products:guidance for industry [EB/OL].[2026-01-28].https://www.fda.gov/media/124795/download., articleTitle=null, refAbstract=null), Reference(id=1325225900211577800, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Considerations for the design and conduct of externally controlled trials for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/164960/download., articleTitle=null, refAbstract=null), Reference(id=1325225901880910793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/171667/download., articleTitle=null, refAbstract=null), Reference(id=1325225901960602570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Data standards for drug and biological product submissions containing real-world data [EB/OL].[2026-01-28].https://www.fda.gov/media/153341/download., articleTitle=null, refAbstract=null), Reference(id=1325225902027711435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Real-world data: assessing registries to support regulatory decision-making for drug and biological products[EB/OL].[2026-01-28].https://www.fda.gov/media/154449/download., articleTitle=null, refAbstract=null), Reference(id=1325225902094820300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/152503/download., articleTitle=null, refAbstract=null), Reference(id=1325225902174512077, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guideline on registry-based studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-registry-based-studies_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225902258398158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Good practice guide for the use of the HMA-EMA catalogues of real-world data sources and studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-use-hma-ema-catalogues-real-world-data-sources-studies_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225902375838671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.List of metadata for the HMA-EMA catalogues of real-world data sources and studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/other/list-metadata-hma-ema-catalogues-real-world-data-sources-studies_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225902455530448, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guide on real-world evidence provided by EMA:support for regulatory decision-making [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/real-world-evidence., articleTitle=null, refAbstract=null), Reference(id=1325225902535222225, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=MHRA.MHRA guideline on randomised controlled trials using real-world data to support regulatory decisions[EB/OL].[2026-01-28].https://www.gov.uk/government/publications/mhra-guideline-on-randomised-controlled-trials-using-real-world-data-to-support-regulatory-decisions., articleTitle=null, refAbstract=null), Reference(id=1325225902619108306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MHRA.MHRA guidance on the use of real-world data in clinical studies to support regulatory decisions[EB/OL].(2025-07-17)[2026-01-28].https://www.gov.uk/government/publications/mhra-guidance-on-the-use-of-real-world-data-in-clinical-studies-to-support-regulatory-decisions., articleTitle=null, refAbstract=null), Reference(id=1325225902690411475, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=CADTH.Use of real-world evidence in single-drug assessments [EB/OL].[2026-01-28].https://www.cda-amc.ca/sites/default/files/pdf/es0323-rwe-in-single-drug-appraisal.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225902753326036, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=CADTH. Optimizing the use of real world evidence to inform regulatory decision-making [EB/OL].[2026-01-28].https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/optimizing-real-world-evidence-regulatory-decisions.html., articleTitle=null, refAbstract=null), Reference(id=1325225902833017813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=PMDA.Development of basic principles in conducting a validation of outcome definitions used in post-marketing database studies [EB/OL].(2020-07-31)[2026-01-28].https://www.pmda.go.jp/files/000270248.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225902929486806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=PMDA.Basic principles on utilization of registry for applications [EB/OL].(2021-03-23)[2026-01-28].https://www.pmda.go.jp/files/000240810.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225903004984279, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=MAHENDRARATNAM N, MERCON K, GILL M, et al.Understanding use of real-world data and real-world evidence to support regulatory decisions on medical product effectiveness [J]. Clin Pharmacol Ther, 2022, 111(1): 150-154., articleTitle=null, refAbstract=null), Reference(id=1325225903088870360, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J, CHEN J, ZHAO J, et al. Establishment of RWS guidance reflecting contributions of China to regulatory science [J]. J Biopharm Stat, 2024, 34(6): 864-872., articleTitle=null, refAbstract=null), Reference(id=1325225903181145049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=PRILLA S, GROENEVELD S, PACURARIU A, et al. Real-world evidence to support EU regulatory decision making-results from a pilot of regulatory use cases [J]. Clin Pharmacol Ther, 2024, 116(5): 1188-1197., articleTitle=null, refAbstract=null), Reference(id=1325225903252448218, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=王 雪, 杨 悦.真实世界证据应用于儿科医药产品研发中的挑战及对策研究[J].中国药房, 2021, 32(10): 1165-1172., articleTitle=null, refAbstract=null), Reference(id=1325225903327945691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=MOHETAER M, TUERSUN A, LI P, et al. Drug review and approval policies based on real-world evidence in china and the United States: a comparative study [J]. Clin Ther, 2024,46(12): 1059-1068., articleTitle=null, refAbstract=null), Reference(id=1325225903403443164, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=徐景和.药械真实世界数据研究应用的若干思考[J].中国食品药品监管, 2023, (6): 4-11., articleTitle=null, refAbstract=null), Reference(id=1325225903478940637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=NISHIOKA K, MAKIMURA T, ISHIGURO A, et al.Evolving acceptance and use of RWE for regulatory decision making on the benefit/risk assessment of a drug in Japan [J].Clin Pharmacol Ther, 2022, 111(1): 35-43., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325225895123886999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=2., ext=[AuthorCompanyExt(id=1325225895136469912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1325225895149052825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.05.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.05.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.05.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.05.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1778342400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
真实世界数据应用于儿童用药研发监管决策的思考
凌星 1 , 何洁 1 , 郭文 1, 2, *
中国医药工业杂志 | 药学管理与信息 2026,57(5): 612-618
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2026 , 57 (5) : 612 -618
真实世界数据应用于儿童用药研发监管决策的思考
全屏
[Author(id=1325225895216161691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225895295853469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895216161691, language=EN, stringName=Xing LING, firstName=Xing, middleName=null, lastName=LING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225895358768030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895216161691, language=CN, stringName=凌星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海 201203, bio={"content":"

凌星,博士研究生,专业方向:医药政策与法规。

"}, bioImg=null, bioContent=

凌星,博士研究生,专业方向:医药政策与法规。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)])]), Author(id=1325225895425876896, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225895509762978, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895425876896, language=EN, stringName=Jie HE, firstName=Jie, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225895593649059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895425876896, language=CN, stringName=何洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)])]), Author(id=1325225895685923749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225895774004136, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895685923749, language=EN, stringName=Wen GUO, firstName=Wen, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.China National Pharmaceutical Industry Information Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225897460114346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, authorId=1325225895685923749, language=CN, stringName=郭文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225895027418004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=1., ext=[AuthorCompanyExt(id=1325225895035806613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325225895048389526, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895027418004, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325225895123886999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, xref=2., ext=[AuthorCompanyExt(id=1325225895136469912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1325225895149052825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225227176784141, companyId=1325225895123886999, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])])]
凌星1, 何洁1, 郭文1, 2, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.中国医药工业信息中心,上海 200040
通讯作者:
郭文,研究员,博士生导师,从事社会与管理药学的研究。
作者简介:

凌星,博士研究生,专业方向:医药政策与法规。

Thoughts on the Application of Real-world Data in Regulatory Decision-making for Pediatric Drug Development
Xing LING1, Jie HE1, Wen GUO1, 2, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.China National Pharmaceutical Industry Information Center, Shanghai 200040
出版时间: 2026-05-10 doi: 10.16522/j.cnki.cjph.2026.05.016
文章导航
收藏切换

儿童用药因研发周期长、市场规模小及临床试验难度大,形成了高成本与低研发意愿的现状。真实世界研究作为一种新研究方法,有望成为解决儿童用药研发困境的突破口。真实世界数据(RWD)整合了电子健康档案、疾病登记等多源信息,可替代部分传统临床试验,用以支持儿童新药有效性评价、剂量优化、适应证扩展及长期安全性评价,助力完善药品说明书中的儿童用药信息。文章梳理、归纳了国内外RWD在儿童用药研发与监管决策中的应用进展,以期探讨并推动我国RWD向真实世界证据转化,加快儿童用药研发。

儿童用药  /  真实世界数据  /  真实世界研究  /  监管  /  社会与管理药学
凌星, 何洁, 郭文. 真实世界数据应用于儿童用药研发监管决策的思考. 中国医药工业杂志, 2026 , 57 (5) : 612 -618 . DOI: 10.16522/j.cnki.cjph.2026.05.016
Xing LING, Jie HE, Wen GUO. Thoughts on the Application of Real-world Data in Regulatory Decision-making for Pediatric Drug Development[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (5) : 612 -618 . DOI: 10.16522/j.cnki.cjph.2026.05.016

参考文献 引证文献
排序方式:
[1]
国家卫生健康委员会.中国卫生健康统计年鉴2023[M].北京: 中国协和医科大学出版社, 2024.
[2]
国家统计局.各年龄段人口数[EB/OL].[2025-06-14].https://data.stats.gov.cn/ifnormal.htm?u=/files/html/vchart/vchart_002/vchart_002.html&h=730.
[3]
王 璐, 黄 哲.真实世界证据改善儿童药物临床试验障碍的对策研究[J].中国新药杂志, 2022, 31(19): 1872-1875.
[4]
ICH.ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population [EB/OL].[2026-01-26].https://database.ich.org/sites/default/files/E11_R1_Guideline.pdf.
[5]
国家药品监督管理局药品审评中心.国家药监局药审中心关于公开征求《真实世界证据支持药物研发的基本考虑》意见的通知[EB/OL].(2019-05-29)[2026-01-19].https://www.cde.org.cn/main/news/viewInfoCommon/7e6fb9fc3f066a966a02130f24dbff1c.
[6]
国家药品监督管理局.国家药监局关于发布真实世界证据支持药物研发与审评的指导原则(试行)的通告[EB/OL].(2020-01-03)[2026-01-19].https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20200107151901190.html.
[7]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《真实世界研究支持儿童药物研发与审评的技术指导原则(试行)》的通告[EB/OL].(2020-08-27)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/6906389100848948deb49a484197902b.
[8]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则(试行)》的通告[EB/OL].(2021-04-13)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/2a1c437ed54e7b838a7e86f4ac21c539.
[9]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《患者报告结局在药物临床研发中应用的指导原则(试行)》的通告[EB/OL].(2021-12-27)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/c2f79c22e8678241b030c71523eb300c.
[10]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《基于人用经验的中药复方制剂新药临床研发指导原则(试行)》《基于“三结合”注册审评证据体系下的沟通交流指导原则(试行)》的通告[EB/OL].(2022-04-29)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/8a1682a8d37494732f7f441dd11f5af6.
[11]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《罕见疾病药物临床研究统计学指导原则(试行)》的通告[EB/OL].(2022-06-02)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/058e0d665b785e79b7f4f24dc1dc970c.
[12]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《真实世界证据支持药物注册申请的沟通交流指导原则(试行)》的通告(2023年第6号)[EB/OL].(2023-02-6)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/8b59a85b13019b5084675edc912004f1.
[13]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《药物真实世界研究设计与方案框架指导原则(试行)》的通告(2023年第5号).[EB/OL].(2023-02-6)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/14aac16a4fc5b5841bc2529988a611cc.
[14]
国家药品监督管理局药品审评中心.关于发布《单臂临床试验用于支持抗肿瘤药上市申请的适用性技术指导原则》的通告(2023年第13号)[EB/OL].(2023-03-14)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/9f0c25dee6ba6781af809b36cf682eb6.
[15]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《基于疾病登记的真实世界数据应用指导原则(试行)》的通告[EB/OL].(2024-11-12)[2026-01-20].https://www.cde.org.cn/main/news/viewInfoCommon/a8d3a782d45feebfcc700e79f3d86326.
[16]
南海网.患者年省约20万元!海南让这款创新药从“用得上”到“用得起”[EB/OL].(2025-03-02)[2025-06-18].https://hainan.ifeng.com/c/8hOVisgbTvF.
[17]
张 豪, 耿 莹, 孙艳喆, 等.《真实世界研究支持儿童药物研发与审评的技术指导原则(试行)》起草背景及要点内容[J].中国临床药理学杂志, 2021, 37(2): 197-200.
[18]
BODEMER C, KASZUBA A, KINGO K, et al.Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a phase 3 double-blind randomized, controlled trial [J].J Eur Acad Dermatol Venereol, 2021, 35(4): 938-947.
[19]
诺华制药.诺华可善挺®(司库奇尤单抗)在华获批儿童及青少年银屑病适应证[EB/OL].[2025-06-18].https://www.novartis.com.cn/news/novartis-cosentyx-secukinumab-approved-in-china-for-the-indication-of-psoriasis-in-children-and-adolescents.
[20]
The United States Congress.21st Century Cures Act(public law 114-255)[EB/OL].[2026-01-28].https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf.
[21]
The United States Congress.Food and Drug Administration Reauthorization Act of 2017(FDARA,Public Law 115-52) [EB/OL].[2026-01-28].https://www.congress.gov/crs-product/R44961?q=%7B%22search%22%3A%22Food+and+Drug+Administration+Reauthorization+Act+of+2017+%28FDARA%2C+P.L.+115-52%29.%22% 7D&s=2&r=1.
[22]
FDA.Use of electronic health record data in clinical investigations: guidance for industry [EB/OL].[2026-01-28].https://www.fda.gov/media/97567/download.
[23]
FDA.Framework for FDA’s real-world evidence program[EB/OL].[2026-01-28].https://www.fda.gov/media/120060/download?attachment.
[24]
FDA.Submitting documents using real-world data and real-world evidence to FDA for drug and biological products:guidance for industry [EB/OL].[2026-01-28].https://www.fda.gov/media/124795/download.
[25]
FDA.Considerations for the design and conduct of externally controlled trials for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/164960/download.
[26]
FDA.Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/171667/download.
[27]
FDA.Data standards for drug and biological product submissions containing real-world data [EB/OL].[2026-01-28].https://www.fda.gov/media/153341/download.
[28]
FDA.Real-world data: assessing registries to support regulatory decision-making for drug and biological products[EB/OL].[2026-01-28].https://www.fda.gov/media/154449/download.
[29]
FDA.Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products [EB/OL].[2026-01-28].https://www.fda.gov/media/152503/download.
[30]
EMA.Guideline on registry-based studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-registry-based-studies_en.pdf.
[31]
EMA.Good practice guide for the use of the HMA-EMA catalogues of real-world data sources and studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-use-hma-ema-catalogues-real-world-data-sources-studies_en.pdf.
[32]
EMA.List of metadata for the HMA-EMA catalogues of real-world data sources and studies [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/documents/other/list-metadata-hma-ema-catalogues-real-world-data-sources-studies_en.pdf.
[33]
EMA.Guide on real-world evidence provided by EMA:support for regulatory decision-making [EB/OL].[2026-01-28].https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/real-world-evidence.
[34]
MHRA.MHRA guideline on randomised controlled trials using real-world data to support regulatory decisions[EB/OL].[2026-01-28].https://www.gov.uk/government/publications/mhra-guideline-on-randomised-controlled-trials-using-real-world-data-to-support-regulatory-decisions.
[35]
MHRA.MHRA guidance on the use of real-world data in clinical studies to support regulatory decisions[EB/OL].(2025-07-17)[2026-01-28].https://www.gov.uk/government/publications/mhra-guidance-on-the-use-of-real-world-data-in-clinical-studies-to-support-regulatory-decisions.
[36]
CADTH.Use of real-world evidence in single-drug assessments [EB/OL].[2026-01-28].https://www.cda-amc.ca/sites/default/files/pdf/es0323-rwe-in-single-drug-appraisal.pdf.
[37]
CADTH. Optimizing the use of real world evidence to inform regulatory decision-making [EB/OL].[2026-01-28].https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/optimizing-real-world-evidence-regulatory-decisions.html.
[38]
PMDA.Development of basic principles in conducting a validation of outcome definitions used in post-marketing database studies [EB/OL].(2020-07-31)[2026-01-28].https://www.pmda.go.jp/files/000270248.pdf.
[39]
PMDA.Basic principles on utilization of registry for applications [EB/OL].(2021-03-23)[2026-01-28].https://www.pmda.go.jp/files/000240810.pdf.
[40]
MAHENDRARATNAM N, MERCON K, GILL M, et al.Understanding use of real-world data and real-world evidence to support regulatory decisions on medical product effectiveness [J]. Clin Pharmacol Ther, 2022, 111(1): 150-154.
[41]
WANG J, CHEN J, ZHAO J, et al. Establishment of RWS guidance reflecting contributions of China to regulatory science [J]. J Biopharm Stat, 2024, 34(6): 864-872.
[42]
PRILLA S, GROENEVELD S, PACURARIU A, et al. Real-world evidence to support EU regulatory decision making-results from a pilot of regulatory use cases [J]. Clin Pharmacol Ther, 2024, 116(5): 1188-1197.
[43]
王 雪, 杨 悦.真实世界证据应用于儿科医药产品研发中的挑战及对策研究[J].中国药房, 2021, 32(10): 1165-1172.
[44]
MOHETAER M, TUERSUN A, LI P, et al. Drug review and approval policies based on real-world evidence in china and the United States: a comparative study [J]. Clin Ther, 2024,46(12): 1059-1068.
[45]
徐景和.药械真实世界数据研究应用的若干思考[J].中国食品药品监管, 2023, (6): 4-11.
[46]
NISHIOKA K, MAKIMURA T, ISHIGURO A, et al.Evolving acceptance and use of RWE for regulatory decision making on the benefit/risk assessment of a drug in Japan [J].Clin Pharmacol Ther, 2022, 111(1): 35-43.
2026年第57卷第5期
125
30
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.05.016
  • 接收时间:2025-10-10
  • 首发时间:2026-11-05
  • 出版时间:2026-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-10-10
基金
作者信息
    1.中国医药工业研究总院,上海 201203
    2.中国医药工业信息中心,上海 200040

通讯作者:

郭文,研究员,博士生导师,从事社会与管理药学的研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.05.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏